Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
  • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
  • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
  • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
  • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
  • C07D213/56—Amides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
  • A61K31/5375—1,4-Oxazines, e.g. morpholine
  • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
  • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
  • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Medicinal Chemistry (AREA)
• Public Health (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Epidemiology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Pyridine Compounds (AREA)
• Physics & Mathematics (AREA)
• Condensed Matter Physics & Semiconductors (AREA)
• Crystallography & Structural Chemistry (AREA)
• General Physics & Mathematics (AREA)
• Plural Heterocyclic Compounds (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=65517772

Family Applications (1)

Country Status (17)

Families Citing this family (4)

Family Cites Families (20)

• 2018
  • 2018-09-07 JP JP2020536496A patent/JP2020533412A/ja active Pending
  • 2018-09-07 KR KR1020247025684A patent/KR20240119192A/ko active Pending
  • 2018-09-07 EP EP18854688.1A patent/EP3679016B1/en active Active
  • 2018-09-07 BR BR112020004419-9A patent/BR112020004419A2/pt unknown
  • 2018-09-07 EP EP25201944.3A patent/EP4674486A2/en active Pending
  • 2018-09-07 CN CN202410415705.3A patent/CN118439992A/zh active Pending
  • 2018-09-07 US US16/124,281 patent/US10669236B2/en active Active
  • 2018-09-07 FI FIEP18854688.1T patent/FI3679016T3/fi active
  • 2018-09-07 KR KR1020207010105A patent/KR102691700B1/ko active Active
  • 2018-09-07 SG SG11202001868RA patent/SG11202001868RA/en unknown
  • 2018-09-07 MX MX2020002622A patent/MX2020002622A/es unknown
  • 2018-09-07 TW TW107131540A patent/TWI815820B/zh active
  • 2018-09-07 LT LTEPPCT/US2018/049829T patent/LT3679016T/lt unknown
  • 2018-09-07 WO PCT/US2018/049829 patent/WO2019051147A1/en not_active Ceased
  • 2018-09-07 CN CN201880069894.6A patent/CN111278808B/zh active Active
  • 2018-09-07 DK DK18854688.1T patent/DK3679016T3/da active
  • 2018-09-07 CA CA3074831A patent/CA3074831A1/en active Pending
  • 2018-09-07 AU AU2018330163A patent/AU2018330163B2/en active Active
  • 2018-09-07 PT PT188546881T patent/PT3679016T/pt unknown
• 2020
  • 2020-03-01 IL IL272992A patent/IL272992A/en unknown
  • 2020-03-06 MX MX2023001805A patent/MX2023001805A/es unknown
  • 2020-04-27 US US16/858,854 patent/US11230527B2/en active Active
• 2021
  • 2021-12-09 US US17/546,133 patent/US12215083B2/en active Active
• 2023
  • 2023-02-21 AU AU2023201010A patent/AU2023201010B2/en active Active
  • 2023-06-30 JP JP2023107781A patent/JP2023157909A/ja active Pending
• 2024
  • 2024-12-19 US US18/987,655 patent/US20250115555A1/en active Pending
• 2025
  • 2025-06-02 JP JP2025091579A patent/JP2025131661A/ja active Pending

Also Published As

Similar Documents